title: Tanning lamps: health effects and reclassification by the Food and Drug Administration.
abstract: Tanning lamps have long been considered a class I medical device under regulation by the Food and Drug Administration (FDA). A growing body of research has repeatedly documented the association between elective indoor tanning and several negative health consequences. These accepted findings have prompted action by the FDA to officially reclassify tanning lamps as a class II medical device. The main purpose of this review is to update practitioners on the current state of tanning lamp classification and highlight the practical implications of this recent change. This information can be used by clinicians to easily reference this important action, and empower patients with a better understanding of the risks associated with indoor tanning.
authors.affiliation: Wayne State University School of Medicine, Detroit, Michigan.
authors.forename: Alexander
authors.initials: A
authors.lastname: Ernst
authors.affiliation: American Academy of Dermatology Association, Evanston, Illinois.
authors.forename: Amanda
authors.initials: A
authors.lastname: Grimm
authors.affiliation: Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. Electronic address: hlim1@hfhs.org.
authors.forename: Henry W
authors.initials: HW
authors.lastname: Lim
mesh_terms: D016739:Behavior, Addictive / Q000209:etiology; D004864:Equipment and Supplies / Q000145:classification; D006801:Humans; D012878:Skin Neoplasms / Q000209:etiology; D055108:Sunbathing; D014466:Ultraviolet Rays / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
keywords: Food and Drug Administration; addiction; basal cell carcinoma; melanoma; reclassification; squamous cell carcinoma; sunlamps; tanning beds; ultraviolet